Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Receivables - Other of $16.9 million for Q1 2026, up 876.43% year-over-year from $1.7 million in Q1 2025, and up 4918.75% quarter-over-quarter from $336000.0 in Q4 2025.
Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Receivables - Other history runs 8 years deep, the most recent figure standing at $16.9 million for Q1 2026.
- In Q1 2026, Receivables - Other rose 876.43% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (up 876.43% YoY), while the FY2025 annual figure was $2.1 million, up 57.97% from the prior year.
- Receivables - Other for Q1 2026 stood at $16.9 million, up from $336000.0 in the prior quarter.
- The five-year high for Receivables - Other was $16.9 million in Q1 2026, with the low at -$3.2 million in Q1 2023.
- The 5-year median for Receivables - Other is $1.1 million (2024), against an average of $1.9 million.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other surged 7886.96% in 2022, then plunged 1134.31% in 2023.
- Tarsus Pharmaceuticals' Receivables - Other stood at $3.6 million in 2022, then slumped by 97.65% to $84000.0 in 2023, then surged by 83.33% to $154000.0 in 2024, then surged by 118.18% to $336000.0 in 2025, then jumped by 4918.75% to $16.9 million in 2026.
- Business Quant data shows TARS's Receivables - Other at $16.9 million in Q1 2026, $336000.0 in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tarsus Pharmaceuticals | 2.99 Bn | 2.54 Bn | 161.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 336,000.00 |
| Dec 31, 2025 | 336,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |